
Arthroplasty
AAOS: Weighted and uniform doses of tranexamic acid similar in reducing blood loss in TKA
50 patients undergoing primary total knee arthroplasty were randomized to receive either a uniform 1-gram dose or a weighted 20 mg/kg dose of intravenous tranexamic acid. The purpose of this study was to determine whether a uniform dose would be more effective than a weighted dose, with respect to postoperative blood loss and hemoglobin levels. Results indicated that intraoperative, postoperative, and total blood loss were not significantly different between treatment groups, suggesting that the treatments were equally effective.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.